Fri, March 11, 2022

Yasmeen Rahimi Maintained (ALGS) at Buy with Increased Target to $375 on, Mar 11th, 2022

Yasmeen Rahimi of Piper Sandler, Maintained "Aligos Therapeutics, Inc." (ALGS) at Buy with Increased Target from $1,175 to $375 on, Mar 11th, 2022.

Yasmeen has made no other calls on ALGS in the last 4 months.



There is 1 other peer that has a rating on ALGS. Out of the 1 peers that are also analyzing ALGS, all agrees with Yasmeen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Eric Joseph of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $300 on, Friday, January 7th, 2022